An open repository of community-contributed protocols sponsored by Nature Research.
Learn more about Protocol Exchange
Method Article
Shin Kaneko
Kyoto University
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Clinical efficacy demonstrated by chimeric antigen receptor T cell therapy call for further development that could broaden their applicability. One such direction is to develop alternate T-cell sources and T cells differentiated from pluripotent stem cells may be an ideal candidate.
The present protocol provides a feeder-free and scalable method to generate T lymphocytes from induced pluripotent stem cells.
Keywords
T cell immunotherapy, iPS Cells, Differentiation,
Loading...
Version History
CURRENT STATUS: Posted
Version 1
Posted 07 Jan, 2021
No community comments so far
Metrics
Comments: 0
HTML Views: ...
An open repository of community-contributed protocols sponsored by Nature Research.
Learn more about Protocol Exchange
Method Article
Shin Kaneko
Kyoto University
Corresponding Author
Version History
CURRENT STATUS: Posted
Version 1
Posted 07 Jan, 2021
No community comments so far
Metrics
Comments: 0
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Clinical efficacy demonstrated by chimeric antigen receptor T cell therapy call for further development that could broaden their applicability. One such direction is to develop alternate T-cell sources and T cells differentiated from pluripotent stem cells may be an ideal candidate.
The present protocol provides a feeder-free and scalable method to generate T lymphocytes from induced pluripotent stem cells.
Loading...